482 related articles for article (PubMed ID: 31974865)
1. DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m
Shriwas O; Priyadarshini M; Samal SK; Rath R; Panda S; Das Majumdar SK; Muduly DK; Botlagunta M; Dash R
Apoptosis; 2020 Apr; 25(3-4):233-246. PubMed ID: 31974865
[TBL] [Abstract][Full Text] [Related]
2. STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma.
Maji S; Shriwas O; Samal SK; Priyadarshini M; Rath R; Panda S; Das Majumdar SK; Muduly DK; Dash R
Carcinogenesis; 2019 Mar; 40(1):173-183. PubMed ID: 30395230
[TBL] [Abstract][Full Text] [Related]
3. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.
Karmakar S; Rauth S; Nallasamy P; Perumal N; Nimmakayala RK; Leon F; Gupta R; Barkeer S; Venkata RC; Raman V; Rachagani S; Ponnusamy MP; Batra SK
Gastroenterology; 2020 Nov; 159(5):1898-1915.e6. PubMed ID: 32781084
[TBL] [Abstract][Full Text] [Related]
4. m
Zhang S; Zhao BS; Zhou A; Lin K; Zheng S; Lu Z; Chen Y; Sulman EP; Xie K; Bögler O; Majumder S; He C; Huang S
Cancer Cell; 2017 Apr; 31(4):591-606.e6. PubMed ID: 28344040
[TBL] [Abstract][Full Text] [Related]
5. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of TNF-alpha/NFkB/SIRT1 axis drives aggressiveness and cancer stem cells accumulation in chemoresistant oral squamous cell carcinoma.
de Castro LR; de Oliveira LD; Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida OGG; Amorim MLM; Squarize CH; Castilho RM; de Almeida LO
J Cell Physiol; 2024 Feb; 239(2):e31164. PubMed ID: 38149816
[TBL] [Abstract][Full Text] [Related]
7. ALKBH5-mediated m
Hao L; Yin J; Yang H; Li C; Zhu L; Liu L; Zhong J
Aging (Albany NY); 2021 Jan; 13(3):4045-4062. PubMed ID: 33428593
[TBL] [Abstract][Full Text] [Related]
8. Increased FOXM1 Expression by Cisplatin Inhibits Paclitaxel-Related Apoptosis in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma (OSCC) Cell Lines.
Choi HS; Kim YK; Hwang KG; Yun PY
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255409
[TBL] [Abstract][Full Text] [Related]
9. FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.
Chiu WT; Huang YF; Tsai HY; Chen CC; Chang CH; Huang SC; Hsu KF; Chou CY
Oncotarget; 2015 Feb; 6(4):2349-65. PubMed ID: 25537512
[TBL] [Abstract][Full Text] [Related]
10. MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer.
Sayyed AA; Gondaliya P; Mali M; Pawar A; Bhat P; Khairnar A; Arya N; Kalia K
Mol Pharm; 2021 Aug; 18(8):3010-3025. PubMed ID: 34176265
[TBL] [Abstract][Full Text] [Related]
11. Pluripotency transcription factor Nanog and its association with overall oral squamous cell carcinoma progression, cisplatin-resistance, invasion and stemness acquisition.
Kashyap T; Nath N; Mishra P; Jha A; Nagini S; Mishra R
Head Neck; 2020 Nov; 42(11):3282-3294. PubMed ID: 32710593
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
[TBL] [Abstract][Full Text] [Related]
13. CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis.
Mohapatra P; Shriwas O; Mohanty S; Ghosh A; Smita S; Kaushik SR; Arya R; Rath R; Das Majumdar SK; Muduly DK; Raghav SK; Nanda RK; Dash R
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33434185
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA.
Zhang C; Samanta D; Lu H; Bullen JW; Zhang H; Chen I; He X; Semenza GL
Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2047-56. PubMed ID: 27001847
[TBL] [Abstract][Full Text] [Related]
15. pERK-mediated IL8 secretion can enhance the migration, invasion, and cisplatin resistance of CD10-positive oral cancer cells.
Pu Y; Li Q; Wang Y; Xu L; Qiao Q; Guo Y; Guo C
BMC Cancer; 2021 Dec; 21(1):1283. PubMed ID: 34847866
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.
Zhang C; Zhi WI; Lu H; Samanta D; Chen I; Gabrielson E; Semenza GL
Oncotarget; 2016 Oct; 7(40):64527-64542. PubMed ID: 27590511
[TBL] [Abstract][Full Text] [Related]
17. Ketorolac salt is a newly discovered DDX3 inhibitor to treat oral cancer.
Samal SK; Routray S; Veeramachaneni GK; Dash R; Botlagunta M
Sci Rep; 2015 Apr; 5():9982. PubMed ID: 25918862
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma.
Tavares MO; Milan TM; Bighetti-Trevisan RL; Leopoldino AM; de Almeida LO
J Oral Pathol Med; 2022 Jul; 51(6):529-537. PubMed ID: 35678235
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
[TBL] [Abstract][Full Text] [Related]
20. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
